Antibody Events, Conferences and Seminars

2nd Annual Cancer Immunotherapy Summit, 21 - 22 September 2017, Vienna, Austria

Vonlanthen Group of Companies

This Summit is focused on Cancer Immunotherapy, the most promising new cancer treatment approach since the development of the first chemotherapies. This summit brings together leading industry professionals in order to expand the scientific horizons of Cancer Immunotherapy, and discuss the latest advances and improvements in research and...

Microbiome: Translating into Diagnostics and BioTherapeutics Summit, 21 - 22 September 2017, Vienna, Austria

Vonlanthen Group of Companies

The Summit will shed light on current challenges, best practices, and the inside view of the future of Microbiome in relation to precision medicine.We will discuss key findings, critical insights, as well as recommendations for driving efficient strategies within the Microbiome landscape. Key Practical Learning Points of the Summit:• Emerging science and technologies for successful...

Artificial Intelligence in Drug Development Congress, 27 September 2017 – 28 September 2017, London, UK

Oxford Global

Oxford Global Conferences are proud to present the Artificial Intelligence in Drug Development Congress co-located with our 15th Annual Pharmaceutical IT Congress, taking place on the 27-28 September 2017 in London.Over 250 artificial intelligence and pharmaceutical IT attendees representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions.Over 20 presentations, case studies and panel discussions focussed on...

Biosimilars & Biobetters 2017, 27th & 28th September, Holiday Inn Kensington Forum, London UK

SMi Group

SMi Group are thrilled to present the 2017 8th annual conference on Biosimilars & Biobetters taking place on 27th & 28th September in Central London, UK.As the patents for several innovator biologics expire, biopharmaceutical companies are taking the opportunity to develop more affordable forms creating a rapidly booming biosimilars market. However, as the field of biosimilars evolves, challenges in immunogenicity studies, securing market share, exclusivity and...

6th annual Cancer Vaccines Conference, 27th & 28th Sept 2017, Copthorne Tara Hotel, London UK

SMi Group

SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2017 will provide a perfect platform to discuss pioneering clinical developments and the...

Inhalation and Respiratory Drug Products Summit, 28 - 29 September 2017, Berlin, Germany

Vonlanthen Group of Companies

This Summit will include a multitude of different subjects within the field of Inhalation and Respiratory Drug Development. We will be discussing how we develop and design dry powder inhalers; integrate development and scale-up combination products; patient use, compliance and human factors associated with DPIs; the challenges of developing a generic inhalant product; and the analytical approaches and specifications for inhaled medicine. Our panel will be addressing these...

3rd Annual Highly Potent Active Pharmaceutical Ingredients Summit, 5 -6 October 2017, Barcelona, Spain

Vonlanthen Group of Companies

This event provides the appropriate platform for industry leaders to discuss process innovation and technical and safety perspectives for both Highly Potent Active Pharmaceutical Ingredient (HPAPI) manufacturers and outsourcers. This summit will be focusing on the latest market trends for HPAPIs; process development and scale-up; cost-effective production; containment innovations; best manufacturing practices; as well as regulatory updates.Key Practical Learning Points of...

4th Annual Drug Discovery USA Congress, 9 – 10 October 2017 in San Diego, USA

Oxford Global

Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive...

2nd Annual Biomarkers & Precision Medicine USA Congress, 9 - 10 October 2017, San Diego, USA "

Oxford Global

Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research,...

4th Annual Microbiology & Infectious Diseases Asia Congress, 10 - 11 October 2017, Singapore

Oxford Global

Oxford Global Conferences are proud to present the 4th Annual Microbiology & Infectious Diseases Asia Congress, taking place on the 10-11 October 2017 in Singapore. The event is a unique opportunity for over 300 experts working in molecular diagnostics, microbiology, genome sequencing technologies and infectious diseases to hear essential insights into the latest developments and research results that shape the current landscape of the industry.Back by popular demand...